Veeral Haresh Ajmera MD
Hepatology & Liver Transplantation
Associate Professor of Medicine-University of California, San Diego Medical Director of Liver Transplantation
Join to view full profile
9350 Campus Point DrLa Jolla, CA 92037
Phone+1 619-543-1884
Fax+1 619-543-3183
Dr. Ajmera is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 2013 - 2016
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
University of Texas Southwestern Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2029
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2021 Aug 12
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsCardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease.Kelly Torosian, Luis Antonio Díaz, Kaleb Tesfai, Weiyu Wu, Katherine M Cooper
Clinical Gastroenterology and Hepatology. 2026-10-01 - Reply to Singh and Anirvan.Veeral Ajmera, Daniel Q Huang, Vincent L Chen, K Rajender Reddy
Gastroenterology. 2026-09-23 - Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis.Veeral Ajmera, Linus Schwantes-An, Luis Antonio Díaz, Callie Zaborenko, Katherine P Yates
Clinical Gastroenterology and Hepatology. 2026-09-16
Press Mentions
Clinical Trials Revolutionize Patient’s Liver DiseaseAugust 25th, 2025- Clinical Trials Revolutionize Patient’s Liver DiseaseAugust 25th, 2025
- Why Is It so Hard to Treat MASH?April 3rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
